Julie Khoury

Statistics

Publications

Citations

1.6K

H-Index

Active since

1992

Affiliations

Alexion Pharmaceuticals (United States)(Current)

University College London

Mayo Clinic in Arizona

Fondazione IRCCS Istituto Neurologico Carlo Besta

National Hospital for Neurology and Neurosurgery

Julie Khoury is an author at Alexion Pharmaceuticals (United States) specializing in medicine, pharmacotherapy, and anti-acetylcholine receptor antibodies.

Publications per year

1992–2023

Publications

Safety and efficacy of eculizumab in anti-acetylcholine receptor antibody-positive refractory generalised myasthenia gravis (REGAIN): a phase 3, randomised, double-blind, placebo-controlled, multicentre study

James F. Howard, Kimiaki Utsugisawa, Michael Benatar et al. · The Lancet Neurology · 2017 · 800 citations

Medicine, Pharmacology, Pharmacotherapy +6

Eplontersen for Hereditary Transthyretin Amyloidosis With Polyneuropathy

Teresa Coelho, Wilson Marques, Noel R. Dasgupta et al. · JAMA · 2023 · 207 citations · Full text

Medicine, Neurology, Pharmacotherapy +16

Defects of mutant DNMT1 are linked to a spectrum of neurological disorders

Jonathan Baets, Xiaohui Duan, Yanhong Wu et al. · Brain · 2015 · 121 citations · Full text

Life Sciences, Genetics, Molecular Genetics +14

COVID-19 Dysautonomia

Brent P. Goodman, Julie Khoury, Janis E. Blair et al. · Frontiers in Neurology · 2021 · 85 citations · Full text

Medicine, Infectious Diseases, Internal Medicine +11

Post-intervention Status in Patients With Refractory Myasthenia Gravis Treated With Eculizumab During REGAIN and Its Open-Label Extension

Renato Mantegazza, Gil I. Wolfe, Srikanth Muppidi et al. · Neurology · 2020 · 79 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +9

1–5 of 12